Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;16(7):566-576.
doi: 10.1161/CIRCIMAGING.122.014988. Epub 2023 Jun 29.

Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure

Affiliations
Free article

Association of Tricuspid Regurgitation With Outcome in Acute Heart Failure

Daniele Cocianni et al. Circ Cardiovasc Imaging. 2023 Jul.
Free article

Abstract

Background: Tricuspid regurgitation (TR) is common in chronic heart failure (HF) and is associated with negative prognosis. However, evidence on prognostic implications of TR in acute HF is lacking. We sought to investigate the association between TR and mortality and the interaction with pulmonary hypertension (PH) in patients admitted for acute HF.

Methods: We enrolled 1176 consecutive patients with a primary diagnosis of acute HF and with available noninvasive estimation of TR and pulmonary arterial systolic pressure.

Results: Moderate-severe TR was present in 352 patients (29.9%) and was associated with older age and more comorbidities. The prevalence of PH (ie, pulmonary arterial systolic pressure >40 mm Hg), right ventricular dysfunction, and mitral regurgitation was higher in moderate-severe TR. At 1 year, 184 (15.6%) patients died. Moderate-severe TR was associated with higher 1-year mortality risk after adjustment for other echocardiographic parameters (pulmonary arterial systolic pressure, left ventricle ejection fraction, right ventricular dysfunction, mitral regurgitation, left and right atrial indexed volumes; hazard ratio, 1.718; P=0.009), and the association with outcome was maintained when clinical variables (eg, natriuretic peptides, serum creatinine and urea, systolic blood pressure, atrial fibrillation) were added to the multivariable model (hazard ratio, 1.761; P=0.024). The association between moderate-severe TR and outcome was consistent in patients with versus without PH, with versus without right ventricular dysfunction, and with versus without left ventricle ejection fraction <50%. Patients with coexistent moderate-severe TR and PH had 3-fold higher 1-year mortality risk compared with patients with no TR or PH (hazard ratio, 3.024; P<0.001).

Conclusions: In patients hospitalized for acute HF, the severity of TR is associated with 1-year survival, regardless of the presence of PH. The coexistence of moderate-severe TR and estimated PH was associated with a further increase in mortality risk. Our data must be interpreted in the context of potential underestimation of pulmonary arterial systolic pressure in patients with severe TR.

Keywords: heart failure; pulmonary hypertension; tricuspid valve; tricuspid valve insufficiency; ventricular dysfunction.

PubMed Disclaimer

Conflict of interest statement

Disclosures Dr Stolfo reports personal fees from Novartis, Merck, GSK, and Acceleron outside the submitted work. Dr Merlo reports consultant and unrestricted fees at congresses, congress fees from Novartis and Vifor Pharma. Dr Sinagra reports consulting fees from Novartis, Impulse Dynamics and Biotronik, and speaker and honoraria from Novartis, Bayer, Astrazeneca, Boston Scientific, Vifor Pharma, Menarini and Akcea Therapeutics outside the submitted work. The other authors report no conflicts

Comment in

MeSH terms